Skip to main content
New Year’s Sale — Build a balanced news diet with 40% off Vantage
Get Started
SubscribeLogin
Published • loading... • Updated

The Endpoints 100: Biotech CEOs are feeling more upbeat about the road ahead

Summary by endpoints.news
Biotech executives show cautious optimism for 2026, with improved sentiment on M&A and hiring despite FDA turmoil under Makary and widespread disapproval of RFK Jr.'s HHS leadership. XBI rise boosts confidence.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

1 Articles

endpoints.newsendpoints.news

The Endpoints 100: Biotech CEOs are feeling more upbeat about the road ahead

Biotech executives show cautious optimism for 2026, with improved sentiment on M&A and hiring despite FDA turmoil under Makary and widespread disapproval of RFK Jr.'s HHS leadership. XBI rise boosts confidence.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Thursday, December 11, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Robert F. Kennedy Jr. icon

Robert F. Kennedy Jr.

Mergers & Acquisitions icon

Mergers & Acquisitions

Business & Markets icon

Business & Markets

Trump Administration icon

Trump Administration

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal